Olema Pharmaceuticals Inc
General ticker "OLMA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $486.6M
Olema Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -2.7%.
Estimated limits based on current volatility of 5.8%: low 5.70$, high 6.40$
Factors to consider:
- Current price 23.4% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.25$, 22.23$]
- 2024-12-30 to 2025-12-30 estimated range: [4.65$, 13.86$]
Financial Metrics affecting the OLMA estimates:
- Negative: Non-GAAP EPS, $ of -2.16 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -12.38 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term OLMA quotes
Long-term OLMA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $71.49MM | $106.99MM | $104.96MM |
| Operating Income | $-71.49MM | $-106.99MM | $-104.96MM |
| Non-Operating Income | $0.40MM | $2.20MM | $8.31MM |
| R&D Expense | $51.10MM | $82.27MM | $86.14MM |
| Income(Loss) | $-71.10MM | $-104.79MM | $-96.66MM |
| Profit(Loss) | $-71.10MM | $-104.79MM | $-96.66MM |
| Stockholders Equity | $284.57MM | $197.55MM | $253.90MM |
| Inventory | $0.35MM | $0.32MM | $0.00MM |
| Assets | $295.94MM | $215.65MM | $276.94MM |
| Operating Cash Flow | $-50.69MM | $-82.06MM | $-83.73MM |
| Capital expenditure | $1.57MM | $0.36MM | $0.00MM |
| Investing Cash Flow | $-275.44MM | $91.48MM | $-4.85MM |
| Financing Cash Flow | $1.39MM | $0.48MM | $133.41MM |
| Earnings Per Share* | $-1.79 | $-2.56 | $-2.14 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.